Journal
VACCINES
Volume 10, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/vaccines10071018
Keywords
foot-and-mouth disease virus; non-structural protein; vaccine purity; chloroform; scale-up
Categories
Funding
- Animal and Plant Quarantine Agency, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea [B-1543386-2022-24-05]
Ask authors/readers for more resources
This study investigated the removal of non-structural proteins (NSPs) in foot-and-mouth disease (FMD) vaccine production. The effectiveness of chloroform treatment varied depending on the virus production medium and was eliminated by detergents. It was found that the removal of 3AB protein by chloroform is due to the transmembrane domain of the N-terminal region. A novel process using ultrafiltration instead of polyethylene glycol precipitation was established for high-purity FMD vaccine antigen production.
Foot-and-mouth disease (FMD) is an economically important and highly infectious viral disease, predominantly controlled by vaccination. The removal of non-structural proteins (NSPs) is very important in the process of FMD vaccine production, because vaccinated and naturally infected animals can be distinguished by the presence of NSP antibodies in the FMD serological surveillance. A previous study reported that 3AB protein, a representative of NSPs, was removed by chloroform treatment. Therefore, in this study, the causes of 3AB removal and factors affecting the effect of chloroform were investigated. As a result, the effectiveness of chloroform differed depending on the virus production medium and was eliminated by detergents. In addition, it was found that 3AB protein removal by chloroform is due to the transmembrane domain of the N-terminal region (59-76 amino acid domain). Further, industrial applicability was verified by applying the chloroform treatment process to scale-up FMD vaccine antigen production. A novel downstream process using ultrafiltration instead of polyethylene glycol precipitation for high-purity FMD vaccine antigen production was established. This result will contribute toward simplifying the conventional process of manufacturing FMD vaccine antigens and ultimately reducing the time and cost of vaccine production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available